Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
May 13th, 2022
FTC To Unveil Proposed Revisions To Endorsement Guides
Advertising Partner Jeffrey A. Greenbaum is quoted in the article, “FTC To Unveil Proposed Revisions To Endorsement Guides” published by MediaPost. The article discusses the Federal Trade Commission’s plan to unveil a long-awaited proposed update to its guidance regarding online endorsements. Jeff is quoted on the guidance saying it will offer an, “important window into what the current commission believes are the key issues” surrounding influencer marketing. He adds, “This is guidance we've been waiting for for a long time” and “Social media and influencer marketing is one of the most important aspects of marketing today and advertisers are anxiously waiting to see what the FTC has to say on these issues.”
Rad the full article here.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
